An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer

Clinical trial NCT04492293 · UNKNOWN

Trial details

NCT number: NCT04492293
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Urothelial Cancer

Start date: 2020-05-27
Primary completion: 2024-12-31
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.